» Articles » PMID: 28455470

Functional Outcome of Debridement, Antibiotics and Implant Retention in Periprosthetic Joint Infection Involving the Hip: a Case-control Study

Overview
Journal Bone Joint J
Date 2017 Apr 30
PMID 28455470
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Advocates of debridement, antibiotics and implant retention (DAIR) in hip periprosthetic joint infection (PJI) argue that a procedure not disturbing a sound prosthesis-bone interface is likely to lead to better survival and functional outcome compared with revision. This case-control study aims were to compare outcome of DAIRs for infected primary total hip arthroplasty (THA) with outcomes following primary THA and two-stage revision of infected primary THAs.

Patients And Methods: We retrospectively reviewed all DAIRs, performed for confirmed infected primary hip arthropasty (n = 82) at out institution, between 1997 and 2013. Data recorded included full patient information and type of surgery. Outcome measures included complications, mortality, implant survivorship and functional outcome. Outcome was compared with two control groups matched for gender and age; a cohort of primary THAs (n = 120) and a cohort of two-stage revisions for infection (n = 66).

Results: Mean age at DAIR was 69 years (33 to 87) and mean follow-up was eight years (2 to 17; standard deviation (sd) 5). A total of 52 (63%) of DAIRs were for early PJI (less than six weeks). Greater success in the eradication of infection with DAIR was identified with early PJI, comprising an interval less than a week between onset of symptoms and exchange of modular components with the DAIR procedure. Eradication of infection, complications and re-operation rates were similar in the DAIR and two-stage revision groups. For hips with successful eradication of infection with DAIR, the five-year survival (98%; 95% confidence interval (CI) 94 to 100) was similar to the primary THA group (98%; 95% CI 95 to 100) (n = 43; p = 0.3). The DAIR group had inferior mean Oxford Hip Scores (OHS) (38; 12 to 48) compared with the primary THA group (42; 15 to 48) (p = 0.02) but a significantly better mean OHS compared with the two-stage revision group (31; 0 to 48) (p = 0.008). Patients who required only one DAIR for eradication of infection had a similar mean OHS (41; 20 to 48) to the primary THA group (p = 0.2).

Conclusion: The DAIR procedure is associated with a similar complication rate and ability to eradicate infection as two-stage revision. This study emphasises the need for exchange of modular components for improved chances of eradication of infection. This is the first study showing that DAIR is better than a two-stage revision regarding functional outcome. Cite this article: 2017;99-B:614-22.

Citing Articles

Long-Term Outcome of Treating Periprosthetic Hip Joint Infection with Local Antibiotics Delivered Through Antibiotic-Impregnated Calcium Hydroxyapatite.

Wakabayashi H, Hasegawa M, Naito Y, Tone S, Sudo A J Clin Med. 2024; 13(23).

PMID: 39685927 PMC: 11642245. DOI: 10.3390/jcm13237469.


Systemic antibiotic prophylaxis in arthroplasty - a narrative review of how many doses are optimal.

Wahl P, Drennan P, Schlappi M, Achermann Y, Leunig M, Gautier E EFORT Open Rev. 2024; 9(12):1106-1119.

PMID: 39620563 PMC: 11619733. DOI: 10.1530/EOR-24-0022.


High and Low Dosage of Vancomycin in Polymethylmethacrylate Cements: Efficacy and Mechanical Properties.

Kwong J, Abramowicz M, Kuhn K, Foelsch C, Hansen E Antibiotics (Basel). 2024; 13(9).

PMID: 39334991 PMC: 11428212. DOI: 10.3390/antibiotics13090818.


Modular component exchange has no advantage in Debridement, Antibiotics and Implant Retention (DAIR) for early onset hip and knee prosthetic joint infection.

Gavaskar A, Tummala N, Srinivasan P, Ayyadurai P, Ganesh D, Reddy R Arch Orthop Trauma Surg. 2024; 144(12):5261-5266.

PMID: 39316104 DOI: 10.1007/s00402-024-05546-5.


The presence of a sinus tract is associated with reinfection after two-stage revision surgery for prosthetic hip joint infection: a case-control study.

Xu H, Li S, Liu S, Li S, Yin Z, Du Y BMC Musculoskelet Disord. 2024; 25(1):721.

PMID: 39244574 PMC: 11380202. DOI: 10.1186/s12891-024-07840-0.